Wilms tumor gene single nucleotide polymorphism rs16754 predicts a favorable outcome in children with acute lymphoblastic leukemia

[1]  J. Chen,et al.  Association between the Polymorphism rs3217927 of CCND2 and the Risk of Childhood Acute Lymphoblastic Leukemia in a Chinese Population , 2014, PloS one.

[2]  S. Raimondi,et al.  The prognostic effect of high diagnostic WT1 gene expression in pediatric AML depends on WT1 SNP rs16754 status: Report from the Children's Oncology Group , 2014, Pediatric blood & cancer.

[3]  P. Bolufer,et al.  Analysis of SNP rs16754 of WT1 gene in a series of de novo acute myeloid leukemia patients , 2012, Annals of Hematology.

[4]  Yunsuk Choi,et al.  Single nucleotide polymorphism of Wilms’ tumor 1 gene rs16754 in Korean patients with cytogenetically normal acute myeloid leukemia , 2012, Annals of Hematology.

[5]  Julia Kuhn,et al.  WT1 synonymous single nucleotide polymorphism rs16754 correlates with higher mRNA expression and predicts significantly improved outcome in favorable-risk pediatric acute myeloid leukemia: a report from the children's oncology group. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  R. Pieters,et al.  No prognostic impact of the WT1 gene single nucleotide polymorphism rs16754 in pediatric acute myeloid leukemia. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  E. Thiel,et al.  Prognostic implications of mutations and expression of the Wilms tumor 1 (WT1) gene in adult acute T-lymphoblastic leukemia , 2010, Haematologica.

[8]  J. V. van Dongen,et al.  Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study. , 2010, Blood.

[9]  K. Döhner,et al.  Single nucleotide polymorphism in the mutational hotspot of WT1 predicts a favorable outcome in patients with cytogenetically normal acute myeloid leukemia. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  J. Harbott,et al.  Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000 , 2010, Leukemia.

[11]  E. Thiel,et al.  Wilms’ tumor gene 1 (WT1) expression in subtypes of acute lymphoblastic leukemia (ALL) of adults and impact on clinical outcome , 2009, Annals of Hematology.

[12]  E. Coustan-Smith,et al.  WT1 protein expression in childhood acute leukemia , 2008, American journal of hematology.

[13]  M. Minden,et al.  A tumor suppressor and oncogene: the WT1 story , 2007, Leukemia.

[14]  M. Kalmanti,et al.  Quantitative assessment of PRAME expression in diagnosis of childhood acute leukemia. , 2007, Leukemia research.

[15]  D. Cilloni,et al.  Quantitative assessment of WT1 expression in diagnosis of childhood acute leukemia. , 2007, Leukemia research.

[16]  J. Starý,et al.  Wilms' tumor gene 1 (WT1) expression in childhood acute lymphoblastic leukemia: a wide range of WT1 expression levels, its impact on prognosis and minimal residual disease monitoring , 2006, Leukemia.

[17]  Toshiki Yoshimine,et al.  Overexpression of the Wilms' tumor gene WT1 in primary astrocytic tumors , 2004, Cancer science.

[18]  M. Monden,et al.  Overexpression of the Wilms' tumor gene WT1 in colorectal adenocarcinoma , 2003, Cancer science.

[19]  C. B. Patel,et al.  Wilms' tumor suppressor gene (WT1) is expressed in primary breast tumors despite tumor-specific promoter methylation. , 2001, Cancer research.

[20]  Y. Oji,et al.  Suppression of Wilms' tumor gene (WT1) expression induces G2/M arrest in leukemic cells. , 1998, Leukemia research.

[21]  T. Kudoh,et al.  Growth inhibition of human leukemic cells by WT1 (Wilms tumor gene) antisense oligodeoxynucleotides: implications for the involvement of WT1 in leukemogenesis. , 1996, Blood.

[22]  E. Thiel,et al.  Presence of Wilms' tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias. , 1995, Leukemia.

[23]  D. Housman,et al.  Alternative splicing and genomic structure of the Wilms tumor gene WT1. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[24]  D. Housman,et al.  Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus , 1990, Cell.

[25]  K. Sailaja,et al.  Association of thymidylate synthase 5'-UTR 28bp tandem repeat and serine hydroxymethyltransfarase C1420T polymorphisms with susceptibility to acute leukemia. , 2014, Asian Pacific journal of cancer prevention : APJCP.